EFFECTS OF K+-CANRENOATE ON THE DEVELOPMENT OF DOCA-SALT HYPERTENSION

被引：6

作者：

VARGAS, F

HARO, JM

JODAR, E

SOLER, A

DELRIO, CG

机构：

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1989年 / 41卷 / 05期

关键词：

D O I：

10.1111/j.2042-7158.1989.tb06467.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：335 / 338

页数：4

共 23 条

[1]

ALTMAN J, 1975, PATHOL BIOL, V24, P337

[2]

BLAUSTEIN MP, 1977, AM J PHYSIOL, V232, pC156

[3]

CASANOVA L, 1986, 8 REUN LIG ESP HIP A, P121

[4]

DEMENDONCA M, 1985, J HYPERTENS, V3, P173

[5]

DEWARDENER HE, 1982, LANCET, V1, P374

[6]

FINOTTI P, 1981, J PHARMACOL EXP THER, V217, P784

[7] CANRENOATE REVERSAL OF INHIBITORY EFFECTS OF DIGOXIN ON BASAL AND FUROSEMIDE-STIMULATED RENIN SECRETION [J].

FINOTTI, P ;

ANTONELLO, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :1-6

[8] THE INTERACTION OF CANRENONE WITH THE NA+,K+ PUMP IN HUMAN RED BLOOD-CELLS [J].

GARAY, RP ;

DIEZ, J ;

NAZARET, C ;

DAGHER, G ;

ABITBOL, JP .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (03) :311-315

[9]

GARRET ER, 1971, J PHARM SCI, V160, P1801

[10]

GRUBER KA, 1983, NATURE, V305, P646, DOI 10.1038/305646a0

← 1 2 3 →